FP
EBS icon

Foundry Partners’s Emergent Biosolutions EBS Stock Holding History

Foundry Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,146
Closed -$1.5M – 393
2021
Q1 		$1.5M Sell
16,146
-2,303
-12% -$236K 0.05% 318
2020
Q4 		$1.65M Sell
18,449
-82
-0.4% -$7.53K 0.06% 302
2020
Q3 		$1.92M Sell
18,531
-77,203
-81% -$8.32M 0.09% 254
2020
Q2 		$7.57M Buy
95,734
+67,025
+233% +$4.99M 0.37% 99
2020
Q1 		$1.66M Sell
28,709
-20,162
-41% -$1.16M 0.09% 242
2019
Q4 		$2.64M Sell
48,871
-1,163
-2% -$63.1K 0.1% 236
2019
Q3 		$2.62M Sell
50,034
-489
-1% -$22.8K 0.11% 232
2019
Q2 		$2.44M Sell
50,523
-151
-0.3% -$7.24K 0.1% 240
2019
Q1 		$2.56M Sell
50,674
-3,109
-6% -$183K 0.1% 248
2018
Q4 		$3.19M Buy
53,783
+387
+0.7% +$24.9K 0.14% 214
2018
Q3 		$3.52M Sell
53,396
-81
-0.2% -$4.73K 0.13% 232
2018
Q2 		$2.7M Sell
53,477
-3,283
-6% -$171K 0.11% 250
2018
Q1 		$2.99M Sell
56,760
-266
-0.5% -$13.3K 0.13% 238
2017
Q4 		$2.65M Sell
57,026
-44,496
-44% -$1.87M 0.11% 239
2017
Q3 		$4.11M Buy
101,522
+10,014
+11% +$362K 0.16% 220
2017
Q2 		$3.1M Sell
91,508
-5,262
-5% -$162K 0.13% 261
2017
Q1 		$2.81M Sell
96,770
-212
-0.2% -$6.45K 0.12% 273
2016
Q4 		$3.19M Buy
+96,982
New +$2.91M 0.14% 252

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Foundry Partners's EBS Position: Q2 2021 in Review

Foundry Partners sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 16,146 shares — an estimated $1.5M sold.

Foundry Partners first reported a position in EBS in Q4 2016 and held it in 18 quarters. The position peaked at $7.57M in Q2 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Foundry Partners reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Foundry Partners sold 16,146 Emergent Biosolutions shares in Q2 2021, an estimated $1.5M.
  • Foundry Partners first reported a position in Emergent Biosolutions in Q4 2016 and held it in 18 quarters.
  • Foundry Partners's Emergent Biosolutions position peaked at $7.57M in Q2 2020.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Foundry Partners's 13F filing for Q2 2021, filed 23 Jul 2021.